| abstract |
The invention relates to novel N-hydroxyacrylamide compounds and pharmaceutically acceptable salts thereof. More specifically, it relates to novel N-hydroxyacrylamide compounds and pharmaceutically acceptable salts thereof acting as an HDAC inhibitor, a pharmaceutical composition containing them and a method of therapeutically using them in the treatment and / or prevention of HDAC-related disease. |